Antimicrobial susceptibility test kit MIKROLATEST® BP

bacteriaenterobacteriaceaestrip

MIKROLATEST® BP kits are antibiotic susceptibility testing (AST) panels based on bacterial growth in breakpoint concentrations of defined antibiotics. Breakpoints refer to standards of European Committee for Antimicrobial Susceptibility Testing – EUCAST issued in January 2011. Most of the antibiotics are represented by two (in exceptional cases one or three) breakpoint concentrations which enable interpretation to three categories: sensitive, intermediate or resistant. These categories are characterised by EUCAST* as follows: Microorganism is defined as sensitive by a level of antimicrobial activity associated with a high probability of therapeutic success, Microorganism is defined as intermediate by a level of antimicrobial activity associated with uncertain therapeutic effect, Microorganism is defined as resistant by a level of antimicrobial activity associated with a high probability of therapeutic failure. In each test system there is a growth control. SENSILATEST G-I The kit is designed to test antimicrobial susceptibility of bacteria from Enterobacteriaceae family. The kit contains 60 detection strips. It enables prognosis of ESBL production. We recommend to use SENSILAtest G-I together with SENSILATEST G-II to test susceptibility of antibiotics aimed for treatment of serious infections especially in hospitalized patients. SENSILATEST G-II The kit is designed to test antimicrobial susceptibility of bacteria from Enterobacteriaceae family. It enables prognosis of ESBL production. The antibiotics in this kit are aimed for treatment of serious infections especially in hospitalized patients.